Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share (the "Shares")
-
Shares outstanding
-
22,396,688
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
13,012,498
-
Shares change
-
+72,676
-
Total reported value, excl. options
-
$19,647,091
-
Value change
-
-$249,812
-
Number of buys
-
19
-
Number of sells
-
22
-
Price
-
$1.51
Institutional Holders of Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD) as of Q1 2025
As of 31 Mar 2025 Boundless Bio, Inc. - Common stock, par value $0.0001 per share (the "Shares") (BOLD) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,012,498 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., Nextech Invest, Ltd., CITADEL ADVISORS LLC, Redmile Group, LLC, SECTORAL ASSET MANAGEMENT INC, BlackRock, Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP.
This table shows 52 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.